Key Highlights: Implications: Anupam Rasayan’s acquisition of a 48.2% controlling stake in Bliss GVS Pharma at ₹299/share completes its forward integration into finished‑dose formulations,...
Key Highlights: Implications:The acquisition gives ChrysCapital control of a long-established branded-generics platform with trusted brands such as Voveran, Calcium Sandoz and Tegrital, positioning th...
Key Highlights: Implications: Sun Pharma is making its biggest strategic pivot yet with the planned all‑cash takeover of Organon, using the deal to jump from an India‑anchor...
